Breast cancer patient featured in The Cancer Letter receives testing for COVID-19, awaits results

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Last week, The Cancer Letter spoke with Janice Cowden, a patient with metastatic breast cancer and symptoms of COVID-19—who was denied testing despite being especially vulnerable to the disease (The Cancer Letter, March 20).

Cowden has since received two tests for COVID-19—a nasopharyngeal swab at a curbside clinic, and a throat pharyngeal swab at the office of her primary care physician. She has yet to receive the results of either test.

Prior to developing symptoms, Cowden had attended a fundraiser with about 300 people—including dozens of women with metastatic breast cancer.

Table of Contents

YOU MAY BE INTERESTED IN

As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login